Beauty Health (NASDAQ:SKIN) stock fell ~4% on June 30, which also  Canaccord Genuity cut its price target on the California-based company’s shares to $20 from $22, but maintained a Buy rating.

The SA Quant Rating on SKIN is Hold, which which takes into account factors such as growth and profitability, among others things. The rating is in contrast to the average Wall Street Analysts’ Rating of Strong Buy, wherein 7 out of 11 analysts call it a Strong Buy.

YTD, Beauty Health’s stock has declined ~46%. The chart below shows YTD price-return performance of SKIN and peers Nu Skin Enterprises, Edgewell Personal Care and Herbalife Nutrition, against SP500TR.


Leave a Reply

Your email address will not be published. Required fields are marked *